DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo


265.39 1.64 (0.62%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACT $265.39 0.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $263.75
Previous Close $263.75
Daily Range $261.79 - $267.61
52-Week Range $161.92 - $272.75
Market Cap $70.3B
P/E Ratio -51.82
Dividend (Yield) $0.00 (0.0%)
Volume 3,527,584
Average Daily Volume 3,725,286
Current FY EPS $13.58





ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website:

News & Commentary

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

Merrill Lynch Top Healthcare Stock Picks for 2015

Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo

The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?

In this week's Industry Focus, our analysts discuss their favorites of the successful 2014 healthcare large-cap stocks.

Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog

Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside

9 Big Stocks That Doubled in 2014

Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog

Alexion Announces New Share Repurchase Program of $500M - Analyst Blog

Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog

See More ACT News...

ACT's Top Competitors

ACT $265.39 (0.62%)
Current stock: ACT
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY